Oracle Buys Drug Trial Software Firm (ORCL)
Oracle Corp. (NASDAQ: ORCL) has announced that it will acquire ClearTrial, a maker of cloud-based Clinical Trial Operations applications for an undisclosed sum. The transaction is expected to close in ...Read Full Story »
